Aldosterone antagonists. 1. Synthesis and biological activities of 11.beta.,18-epoxypregnane derivatives

Authors:
  • SKSusumu Kamata
    Susumu Kamata
  • NHNobuhiro Haga
    Nobuhiro Haga
  • TMTakashi Mitsugi
    Takashi Mitsugi
  • EKEiji Kondo
    Eiji Kondo
  • WNWataru Nagata
    Wataru Nagata
  • MNMasuhisa Nakamura
    Masuhisa Nakamura
  • KMKenji Miyata
    Kenji Miyata
  • KOKunihiro Odaguchi
    Kunihiro Odaguchi
  • TSToshikatsu Shimizu
    Toshikatsu Shimizu

Abstract
Several steroid derivatives having the 11.beta.,18-epoxypregnane skeleton [9.alpha.-fluoro 21-hydroxy-11.beta., 18-epoxypregn-4-ene-3,20-dione, 3-(17.beta.-hydroxy-11.beta.,18-epoxy-3-oxoandrost-4-en-17.alpha.-yl)propionic acid .gamma.-lactone, 3-(17.beta.-hydroxy-11.beta.,18-epoxy-3-oxoandrosta-4,6-dien-17.alpha.-yl)propionic acid .gamma.-lactone and 3-[7.alpha.-(acetylthio)-17.beta.-hydroxy-11.beta.,18-epoxy-3-oxo-androst-4-en-17-.alpha.-yl]propionic acid .gamma.-lactone] and 31, were synthesized to evaulate their antialdosterone activity. Among them, 3-(9.alpha.-fluoro-17.beta.-hydroxy-3-oxoandrost-4-en-17.alpha.-yl)propionic acid .gamma.-lactone (31) possessed fairly strong binding affinity for the cytoplasmic mineralocorticoid receptor of rat kidney and exhibited good aldosterone antagonist activity in an in vivo assay. Its agonistic nature cannot be igored. The properties of 31 as an aldosterone antagonist were enhanced by its very low to negligible binding affinity for the androgen, progestin, estrogen and glucocorticoid receptors.